1-Naphthalenemethanamine, N-(6,6-dimethyl-2-hepten-4-ynyl)-N-methyl-, (E)-,monohydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

61 Suppliers, 27 USDMF, 23 CEP/COS, 17 JDMF, 14 EU WC, 36 KDMF, 27 NDC API, 28 Listed Suppliers

DEVELOPMENTS

4 Drug(s) in Development

4 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

7 Suppliers

7 Suppliers

DOSSIERs // Finished Dosage Forms

122 Dossiers, 25 FDA Orange Book, 53 Europe, 10 Canada, 14 South Africa, 20 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 1%, SOLUTION;TOPICAL - 1%, GRANULE;ORAL - EQ 125MG BASE/PACKET, GRANULE;ORAL - EQ 187.5MG BASE/PACKET

RELATED EXCIPIENT COMPANIES

Suppliers, 21 BASF, 16 Kerry, 10 Corel Pharma Chem, 10 Roquette, 10 Sigachi Industries, 9 Microlex e.U, 8 Gangwal Chemicals, 8 Seppic, 7 Gangwal Healthcare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 Lonza Capsugel, 6 Nanjing Well Pharmaceutical, 5 Ideal Cures Pvt Ltd, 4 DFE Pharma, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Prachin Chemical, 4 Vasa Pharmachem, 4 Actylis, 3 Finar, 3 Seqens, 3 Kima Chemical, 2 Pharmatrans-Sanaq, 2 Nomisma Healthcare, 2 Ingredion Pharma Solutions, 2 The Dow Chemical Company, 1 Vertellus, 1 Jai Radhe Sales, 1 SPI Pharma, 1 ACG Worldwide, 1 Qualicaps, 1 Qianhao Chemical (Hebei) Co., Ltd

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives, 27 Controlled & Modified Release, 25 Disintegrants & Superdisintegrants, 25 Fillers, Diluents & Binders, 21 Topical, 18 Thickeners and Stabilizers, 15 Solubilizers, 15 Direct Compression, 14 Lubricants & Glidants, 14 Granulation, 7 Film Formers & Plasticizers, 7 Emulsifying Agents, 6 Parenteral, 6 Co-Processed Excipients, 6 Taste Masking, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Rheology Modifiers, 3 Chewable & Orodispersible Aids, 3 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions, 19 Finished Drug Prices

MARKET PLACE

14 APIs

14 APIs

PATENTS

5 Health Canada Patents

5 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 2 EDQM Standards, 1 USP Standards, 2 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 2 News

Approved Drug Products containing 1-Naphthalenemethanamine, N-(6,6-dimethyl-2-hepten-4-ynyl)-N-methyl-, (E)-, monohydrochloride listed in the FDA Orange Book. Original Data : FDA Website

1-Naphthalenemethanamine, N-(6,6-dimethyl-2-hepten-4-ynyl)-N-methyl-, (E)-,monohydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

61 Suppliers

27 USDMF

23 CEP/COS

17 JDMF

14 EU WC

36 KDMF

27 NDC API

28 Listed Suppliers

DEVELOPMENTS

4 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

7 Suppliers

DOSSIERs // Finished Dosage Forms

122 Dossiers

25 FDA Orange Book

53 Europe

10 Canada

14 South Africa

20 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 1%

SOLUTION;TOPICAL - 1%

GRANULE;ORAL - EQ 125MG BASE/PACKET

GRANULE;ORAL - EQ 187.5MG BASE/PACKET

RELATED EXCIPIENT COMPANIES

Suppliers

21 BASF

16 Kerry

10 Corel Pharma Chem

10 Roquette

10 Sigachi Industries

9 Microlex e.U

8 Gangwal Chemicals

8 Seppic

7 Gangwal Healthcare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 Lonza Capsugel

6 Nanjing Well Pharmaceutical

5 Ideal Cures Pvt Ltd

4 DFE Pharma

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Prachin Chemical

4 Vasa Pharmachem

4 Actylis

3 Finar

3 Seqens

3 Kima Chemical

2 Pharmatrans-Sanaq

2 Nomisma Healthcare

2 Ingredion Pharma Solutions

2 The Dow Chemical Company

1 Vertellus

1 Jai Radhe Sales

1 SPI Pharma

1 ACG Worldwide

1 Qualicaps

1 Qianhao Chemical (Hebei) Co., Ltd

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives

27 Controlled & Modified Release

25 Disintegrants & Superdisintegrants

25 Fillers, Diluents & Binders

21 Topical

18 Thickeners and Stabilizers

15 Solubilizers

15 Direct Compression

14 Lubricants & Glidants

14 Granulation

TABLET;ORAL - EQ 250MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons